glp-1 receptor agonist antipsychotic weight gain study New Loss Drugs in Psychiatry Effect of GLP-1 receptor agonists

If we conflate access to drugs with access to quality multidisciplinary care, were going down the wrong path altogether

& Buse, J

The awardees are Daniel Drucker, an endocrinologist at the University of Toronto, Joel Habener, an endocrinologist at Harvard Medical School, Jens Juul Holst, a physiologist at the University of Copenhagen, Lotte Bjerre Knudsen, a pharmaceutical scientist at Novo Nordisk, and Svetlana Mojsov, a chemist at The Rockefeller University

While pancreatitis remains a warning on product labeling and a theoretical concern due to shared pathways, large-scale CVOTs and subsequent meta-analyses have not shown a statistically significant increase in the risk of acute pancreatitis compared to placebo [86]

Introducing the sequence into skin cells enabled Thorens to establish whether it could construct the receptor (Delaye)

These strategies compared to currently available drug medications such as thiazolidinediones, sulphonylureas, and insulin, have the potential to treat diabetes without causing side effects of hypoglycemia and weight gain